341 related articles for article (PubMed ID: 29686152)
1. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
[No Abstract] [Full Text] [Related]
2. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
3. Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC;
J Antimicrob Chemother; 2001 Dec; 48(6):935-6. PubMed ID: 11733486
[No Abstract] [Full Text] [Related]
4. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
5. Characterization of trimethoprim-sulfamethoxazole resistance genes and their relatedness to class 1 integron and insertion sequence common region in gram-negative bacilli.
Shin HW; Lim J; Kim S; Kim J; Kwon GC; Koo SH
J Microbiol Biotechnol; 2015 Jan; 25(1):137-42. PubMed ID: 25348695
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].
Uner MC; Hasçelik G; Müştak HK
Mikrobiyol Bul; 2016 Jan; 50(1):11-20. PubMed ID: 27058325
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Analysis of Antimicrobial Susceptibility Profiles of
Hamdi AM; Fida M; Deml SM; Abu Saleh OM; Wengenack NL
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818815
[No Abstract] [Full Text] [Related]
9. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.
Adrian PV; Klugman KP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2406-13. PubMed ID: 9371341
[TBL] [Abstract][Full Text] [Related]
10. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.
Khalil I; Rønn AM; Alifrangis M; Gabar HA; Satti GM; Bygbjerg IC
Am J Trop Med Hyg; 2003 May; 68(5):586-9. PubMed ID: 12812351
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights of co-trimoxazole resistance genes in Haemophilus influenzae isolated in Malaysia.
Mohd-Zain Z; Kamsani NH; Ahmad N
Trop Biomed; 2013 Dec; 30(4):584-90. PubMed ID: 24522126
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
Suárez I; Roderus L; van Gumpel E; Jung N; Lehmann C; Fätkenheuer G; Hartmann P; Plum G; Rybniker J
Infection; 2017 Jun; 45(3):341-347. PubMed ID: 28303545
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021.
Yang J; Ren HT; Wang J; Dong AY; Chen YL; Hu DX; Wang H; Ji HM; Wen HN; Chen Y; Shi DY
Int J Infect Dis; 2023 May; 130():136-143. PubMed ID: 36871785
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic analysis and whole genome sequencing of two
Wang H; Cheng F; Dong XT; Li XF; Wang YJ; Hao MJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Dec; 54(12):1441-1447. PubMed ID: 33333664
[No Abstract] [Full Text] [Related]
15. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
16. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological study of sulfonamide and trimethoprim resistance genes in Enterobacteriaceae.
Panbangred W; Jayanetra P; Pilantanapak A
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):175-84. PubMed ID: 2237584
[TBL] [Abstract][Full Text] [Related]
19. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
[TBL] [Abstract][Full Text] [Related]
20. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.
Brown-Elliott BA; Biehle J; Conville PS; Cohen S; Saubolle M; Sussland D; Wengenack N; Kriel K; Bridge L; McNulty S; Vasireddy R; Wallace RJ
J Clin Microbiol; 2012 Mar; 50(3):670-2. PubMed ID: 22170936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
